If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Versarien, Blue Star Capital, KR1 & Vadim Alexander on Polarean Imaging
Neill Ricketts, CEO of Versarien #VRS explains their acquisition of a portfolio of patents including CVD graphene manufacturing methods from South Korea based Hanwha Aerospace.
Versarien is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has five subsidiaries operating under two divisions: Graphene and Plastics Thermal and Hardware Products.
Tony Fabrizi, CEO of Blue Star Capital #BLU provides an update in respect of its esports portfolio as well as its investee companies.
Blue Star is an investing company with a focus on new technologies. Blue Star's investments include a 27.7% holding in SatoshiPay, a payments business using blockchain technology; investments in 6 early stage esports companies with shareholdings ranging from 5.9% to 13.6% and a 0.9% investment in Sthaler, an identity and payments technology business which enables a consumer to identify themselves and pay using just their finger.
(Interview starts at 13 minutes 9 seconds)
Keld van Schreven, Co-Founder & Managing Director of KR1 Plc #KR1 talks about the performance of investee companies and why he's bullish for Crypto in 2021.
KR1 is a leading digital asset investment company supporting early-stage decentralised and open source blockchain and DeFi projects. Founded in 2016 and publicly traded in London on the Apex segment of the AQSE Growth Market (KR1: AQSE), KR1 has built a notable reputation for generating significant returns by investing in many key projects that are designed to power the decentralised platforms and protocols that are emerging to form new internet infrastructures.
(Interview starts at 18 minutes)
Vadim Alexandre, Head of Healthcare at SP Angel discusses the FDA acceptance for filing of New Drug Application from Polarean Imaging #POLX
(Interview starts at 28 minutes 3 seconds)